ISPIRON
Business purpose.
Recherche et développement scientifique, technique et commercial de bioprocédés destinés à la fabrication industrielle de molécules à visée thérapeutique. - Etude, conception et le développement scientifique, technique et commercial en vue de la mise au point, la fabrication et la vente de toutes machines spéciales dans le domaine de la biotechnologie. - La prise et l'achat de tous brevets et de toutes marques. - Le développement scientifique et commercial de brevets et marques pour son propre compte ou pour le compte de tiers.
Identity
- Legal form
- SAS, simplified joint-stock company
- Activity
- Research and experimental development on biotechnology (72.11Z)
- Sector
- Scientific research and development
- Headcount
- Headcount unknown
- Created
- 1 Aug 2024
- Share capital
- 40,000.00 EUR
- Financial year end
- 31/12
- Establishments
- 1
Directors
- 5 AS FAMILY Directeur general
- Volahasina Irina GBALOU 39 years old, 09/1987 President de SAS
Related companies
Companies run by the same people. Statutory auditors and liquidators are excluded: they serve in dozens of unrelated companies, and including them would draw groups that do not exist.
- ASTEIA CAPITAL via Volahasina Irina GBALOU
Other companies at the same address
4 other company head offices are registered at this address.
Establishments
Financial strength
Financial score
Cannot be computed, not enough data
Confidence: low
formula fin-1.0
Legal score
65 / 100 B
Confidence: high
- No insolvency proceedings
- 40.0 out of 40
- Currently trading
- 20.0 out of 20
- Age (2.3 years)
- 4.6 out of 20
- Accounts filed recently
- 0.0 out of 20
formula leg-1.0
These scores are computed by us from public data, using a published formula. They are not advice, not a guarantee, not a credit decision, and they do not replace a review of the accounts. See how it is calculated
Explore similar companies
Legal notices
-
Filing of accounts 21 Jul 2026
- Court :
- Greffe du Tribunal de Commerce de troyes
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2025
BODACC C n 20260136, annonce n 1351 · Proof of publication (PDF)
-
Incorporation 13 Aug 2024
- Court :
- Greffe du Tribunal de Commerce de Troyes
BODACC A n 20240156, annonce n 150 · Proof of publication (PDF)
Filings and annual accounts as PDF →
Filings and accounts
- Formality 9 Aug 2024
Change history
- Appointed: Directeur general 9 Oct 2026
- Appointed: President de SAS 9 Oct 2026
- Appointed: Directeur general 9 Oct 2026
- Appointed: President de SAS 9 Oct 2026
- Appointed: Directeur general 9 Oct 2026
- Appointed: President de SAS 9 Oct 2026
- Appointed: Directeur general 9 Oct 2026
- Appointed: President de SAS 9 Oct 2026
- Appointed: Directeur general 9 Oct 2026
- Appointed: President de SAS 9 Oct 2026
- Appointed: Directeur general 9 Oct 2026
- Appointed: President de SAS 9 Oct 2026
- Appointed: Directeur general 9 Oct 2026
- Appointed: President de SAS 9 Oct 2026
- Share capital: 40,000 € 2 Oct 2026
Frequently asked questions about ISPIRON
- What is the SIREN number of ISPIRON?
- The SIREN number of ISPIRON is 931824478. Its intra-community VAT number is FR85931824478.
- Where is the head office of ISPIRON?
- Head office address: 20 CHEMIN DE SAINT PHAL, 10190 BUCEY-EN-OTHE.
- When was ISPIRON founded?
- ISPIRON was founded on 1 Aug 2024.
- What does ISPIRON do?
- Its declared main activity is: Research and experimental development on biotechnology (NAF code 72.11Z).
- Who runs ISPIRON?
- The officers listed in the register are 5 AS FAMILY (Directeur general), Volahasina Irina GBALOU (President de SAS).
- Is ISPIRON subject to insolvency proceedings?
- No ongoing insolvency proceedings are published in the BODACC for this company.